CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation | Zendy

Κonstantinos P. Letsas | Zendy; Michalis Efremidis | Zendy; Γεώργιος Γιαννόπουλος | Zendy; Spyridon Deftereos | Zendy; Louiza Lioni | Zendy; Panagiotis Korantzopoulos | Zendy; Konstantinos Vlachos | Zendy; Sotirios Xydonas | Zendy; Charalambos Kossyvakis | Zendy; Antonios Sideris | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation

Author(s) -

Κonstantinos P. Letsas,

Michalis Efremidis,

Γεώργιος Γιαννόπουλος,

Spyridon Deftereos,

Louiza Lioni,

Panagiotis Korantzopoulos,

Konstantinos Vlachos,

Sotirios Xydonas,

Charalambos Kossyvakis,

Antonios Sideris

Publication year - 2013

Publication title -

ep europace

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.119

H-Index - 102

eISSN - 1532-2092

pISSN - 1099-5129

DOI - 10.1093/europace/eut210

Subject(s) - medicine , atrial fibrillation , cardiology , interquartile range , hazard ratio , cha2ds2–vasc score , confidence interval , catheter ablation , atrial tachycardia , receiver operating characteristic , ablation , area under the curve , coronary artery disease , predictive value of tests , ischemic stroke , ischemia

The selection of patients with atrial fibrillation (AF) that will benefit most by left atrial ablation remains suboptimal. CHADS2 score has been shown to be associated with post-ablation AF recurrences. However, data regarding the CHA2DS2-VASc score are lacking. In addition, there is paucity of data regarding the exact predictive value, in terms of sensitivity and specificity, of each of these scores as to AF recurrence. This study aimed to evaluate the merit of the CHADS2 and CHA2DS2-VASc scores in predicting arrhythmia recurrence after a single ablation procedure for paroxysmal AF.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research